Finally new tools are available to combat drug resistant tuberculosis, but how do we make them work? Models to determine effective implementation strategies in Australia and our region

结核病耐药性风险（MDR TB）正在阻碍控制工作，必须加以解决。正在考虑的潜在战略是：在潜伏期治疗耐多药结核病，对活动性结核病采用新的短程治疗方法，并使用新的疫苗。我的工作是开发模拟模型，在实施战略之前对其进行测试，以最大限度地发挥影响，避免昂贵或低影响的干预措施。我将研究澳大利亚和澳大利亚地区高负担国家的战略。

The risk of drug resistance in tuberculosis (MDR TB) is thwarting control efforts and must be addressed. Potential strategies being considered are; treating MDR TB in the latent phase, using new short-course treatment for active TB and using new vaccines. My work develops simulation models to test strategies before they are implemented, to maximise impact and avoid costly or low-impact interventions. I will examine strategies in Australia and in high burden countries in Australia’s region.